Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives

키워드

참고문헌 (140)

1. Olszewska E., "Etiopathogenesis of cholesteatoma", Eur Arch Otorhinolaryngol, 261(1), pp.6~24 (2004)
2. Soldati D., "Knowledge about cholesteatoma, from the first description to the modern histopathology", Otol Neurotol, 22(6), pp.723~730 (2001)
3. Dornelles C., "Some considerations about acquired adult and pediatric cholesteatomas", Braz J Otorhinolaryngol, 71(4), pp.536~545 (2005)
4. Kuo CL, "Etiopathogenesis of acquired cholesteatoma : prominent theories and recent advances in biomolecular research", Laryngoscope, 125(1), pp.234~240 (2015)
5. Kuo CL., "Updates and knowledge gaps in cholesteatoma research", Biomed Res Int, 2015, pp.854024~ (2015)
6. Aquino JE., "Epidemiology of middle ear and mastoid cholesteatomas : study of 1146 cases", Braz J Otorhinolaryngol, 77(3), pp.341~347 (2011)
7. Chole RA, "The molecular biology of bone resorption due to chronic otitis media", Ann N Y Acad Sci, 830, pp.95~109 (1997)
8. Louw L, "Acquired cholesteatoma : summary of the cascade of molecular events", J Laryngol Otol, 127(6), pp.542~549 (2013)
9. Albino AP., "Cholesteatoma : a molecular and cellular puzzle", Am J Otol, 19(1), pp.7~19 (1998)
10. Meyerhoff WL., "Cholesteatoma staging", Laryngoscope, 96(9 Pt 1), pp.935~939 (1986)
11. Friedmann I., "The comparative pathology of otitis media., experimental and human. II. The histopathology of experimental otitis of the guinea-pig with particular reference to experimental cholesteatoma", J Laryngol Otol, 69(9), pp.588~601 (1955)
12. Lepercque S., "Cytokeratin expression patterns in the human tympanic membrane and external ear canal", Eur Arch Otorhinolaryngol, 250(2), pp.78~81 (1993)
13. Lee RJ., "The nature of the epithelium in acquired cholesteatoma", Clin Otolaryngol Allied Sci, 16(2), pp.168~173 (1991)
14. Imamura S., "Pathogenesis of experimental aural cholesteatoma in the chinchilla", ORL J Otorhinolaryngol Relat Spec, 61(2), pp.84~91 (1999)
15. Persaud R., "Evidence-based review of aetiopathogenic theories of congenital and acquired cholesteatoma", J Laryngol Otol, 121(11), pp.1013~1019 (2007)
16. Kuijpers W., "Squamous metaplasia of the middle ear epithelium", Acta Otolaryngol, 116(2), pp.293~298 (1996)
17. Akyildiz N., "The role of retraction pockets in cholesteatoma development : an ultrastructural study", Ear Nose Throat J, 72(3), pp.210~212 (1993)
18. Chole RA., "Basal lamina breaks in the histogenesis of cholesteatoma", Laryngoscope, 95(3), pp.270~275 (1985)
19. Sudhoff H., "Basement membrane in middle ear cholesteatoma : immunohistochemical and ultrastructural observations", Ann Otol Rhinol Laryngol, 105(10), pp.804~810 (1996)
20. Sudhoff H, "Cholesteatoma behind an intact tympanic membrane : histopathologic evidence for a tympanic membrane origin", Otol Neurotol, 22(4), pp.444~446 (2001)
21. Magnan J., "Anatomo-pathology of cholesteatoma", Acta Otorhinolaryngol Belg, 45(1), pp.27~34 (1991)
22. Kim CS., "Morphologic and biologic changes of experimentally induced cholesteatoma in Mongolian gerbils with anticytokeratin and lectin study", Am J Otol, 20(1), pp.13~18 (1999)
23. Jackler RK., "A new theory on the pathogenesis of acquired cholesteatoma: mucosal traction", Laryngoscope, 125(Suppl 4), pp.S1~S14 (2015)
24. Wullstein HL., "Cholesteatoma : etiology, nosology and tympanoplasty", ORL J Otorhinolaryngol Relat Spec, 42(6), pp.313~335 (1980)
25. McKennan KX., "Post-traumatic cholesteatoma", Laryngoscope, 99(8 Pt 1), pp.779~782 (1989)
26. Falk B., "Evacuation of the middle ear by sniffing : a cause of high negative pressure and development of middle ear disease", Otolaryngol Head Neck Surg, 92(3), pp.312~318 (1984)
27. Magnuson B., "Eustachian tube malfunction and middle eardisease in new perspective", J Otolaryngol, 12(3), pp.187~193 (1983)
28. Lindeman P., "Mastoid volume and eustachian tube function in ears with cholesteatoma", Am J Otol, 8(1), pp.5~7 (1987)
29. Wolfman DE., "Osteoclast stimulation by positive middle-ear air pressure", Arch Otolaryngol Head Neck Surg, 112(10), pp.1037~1042 (1986)
30. Dominguez S., "Incidence of cholesteatoma with cleft palate", Ann Otol Rhinol Laryngol, 97(6 Pt 1), pp.659~660 (1988)
31. Hornigold R., "The long-term effect of unilateral t-tube insertion in patients undergoing cleft palate repair : 20-year follow-up of a randomised controlled trial", Clin Otolaryngol, 33(3), pp.265~268 (2008)
32. Spilsbury K., "Cholesteatoma in cleft lip and palate : a population-based follow-up study of children after ventilation tubes", Laryngoscope, 123(8), pp.2024~2029 (2013)
33. Coker NJ., "Obliteration of the middle ear and mastoid cleft in subtotal petrosectomy: indications, technique, and results", Ann Otol Rhinol Laryngol, 95(1 Pt 1), pp.5~11 (1986)
34. Roland NJ., "The use of ventilation tubes and the incidence of cholesteatoma surgery in the paediatric population of Liverpool", Clin Otolaryngol Allied Sci, 17(5), pp.437~439 (1992)
35. Marchioni D., "Selective epitympanic dysventilation syndrome", Laryngoscope, 120(5), pp.1028~1033 (2010)
36. Marchioni D., "The contribution of selective dysventilation to attical middle ear pathology", Med Hypotheses, 77(1), pp.116~120 (2011)
37. Marchioni D., "Prevalence of ventilation blockages in patients affected by attic pathology : a case-control study", Laryngoscope, 123(11), pp.2845~2853 (2013)
38. Palva T., "Incudal folds and epitympanic aeration", Am J Otol, 17(5), pp.700~708 (1996)
39. Palva T., "Tensor fold and anterior epitympanum", Am J Otol, 18(3), pp.307~316 (1997)
40. Huisman MA., "Transforming growth factor beta and wound healing in human cholesteatoma", Laryngoscope, 118(1), pp.94~98 (2008)
41. Sudhoff H., "Pathogenesis of attic cholesteatoma : clinical and immunohistochemical support for combination of retraction theory and proliferation theory", Am J Otol, 21(6), pp.786~792 (2000)
42. Lim DJ., "Acquired cholesteatoma : light and electron microscopic observations", Ann Otol Rhinol Laryngol, 81(1), pp.1~11 (1972)
43. Alves AL., "Analysis of histopathological aspects in acquired middle ear cholesteatoma", Braz J Otorhinolaryngol, 74(6), pp.835~841 (2008)
44. Dornelles C., "Histologic description of acquired cholesteatomas : comparison between children and adults", Braz J Otorhinolaryngol, 72(5), pp.641~648 (2006)
45. Sade J., "The aetiology of bone destruction in chronic otitis media", J Laryngol Otol, 88(2), pp.139~143 (1974)
46. Bretlau P., "Bone resorption in human cholesteatomas", Ann Otol Rhinol Laryngol, 91(2 Pt 1), pp.131~135 (1982)
47. Kurihara A., "Bone destruction mechanisms in chronic otitis media with cholesteatoma : specific production by cholesteatoma tissue in culture of bone-resorbing activity attributable to interleukin-1 alpha", Ann Otol Rhinol Laryngol, 100(12), pp.989~998 (1991)
48. Jung JY., "Bone resorption in chronic otitis media : the role of the osteoclast", ORL J Otorhinolaryngol Relat Spec, 64(2), pp.95~107 (2002)
49. Maranhao A., "Epidemiology of intratemporal complications of otitis media", Int Arch Otorhinolaryngol, 18(2), pp.178~183 (2014)
50. Chole RA., "Pressure-induced bone resorption in the middle ear", Ann Otol Rhinol Laryngol, 94(2 Pt 1), pp.165~170 (1985)
51. McGinn MD., "Bone resorption induced by middle-ear implants", Arch Otolaryngol Head Neck Surg, 112(6), pp.635~641 (1986)
52. Orisek BS., "Pressures exerted by experimental cholesteatomas", Arch Otolaryngol Head Neck Surg, 113(4), pp.386~391 (1987)
53. Huang CC., "A morphometric study of the effects of pressure on bone resorption in the middle ear of rats", Am J Otol, 11(1), pp.39~43 (1990)
54. Kaneko Y., "Bone destruction due to the rupture of a cholesteatoma sac: a pathogenesis of bone destruction in aural-cholesteatoma", Laryngoscope, 90(11 Pt 1), pp.1865~1871 (1980)
55. Nguyen KH., "Possible participation of acidic pH in bone resorption in middle ear cholesteatoma", Laryngoscope, 124(1), pp.245~250 (2014)
56. Chen ZF., "Hydroxyapatite solubility in simple inorganic solutions", Arch Oral Biol, 49(5), pp.359~367 (2004)
57. Saunders J., "Biofilms in chronic suppurative otitis media and cholesteatoma : scanning electron microscopy findings", Am J Otolaryngol, 32(1), pp.32~37 (2011)
58. Gu X., "Detection of bacterial biofilms in different types of chronic otitis media", Eur Arch Otorhinolaryngol, 271(11), pp.2877~2883 (2014)
59. Chole RA., "Evidence for microbial biofilms in cholesteatomas", Arch Otolaryngol Head Neck Surg, 128(10), pp.1129~1133 (2002)
60. Lampikoski H., "Mastoid biofilm in chronic otitis media", Otol Neurotol, 33(5), pp.785~788 (2012)
61. Van Snick J, "Interleukin-6 : an overview", Annu Rev Immunol, 8, pp.253~278 (1990)
62. Yellon RF., "Characterization of cytokines present in middle ear effusions", Laryngoscope, 101(2), pp.165~169 (1991)
63. Peek FA., "Lipopolysaccharide concentration and bone resorption in cholesteatoma", Otol Neurotol, 24(5), pp.709~713 (2003)
64. Ricciardiello F., "Notes on the microbiology of cholesteatoma : clinical findings and treatment", Acta Otorhinolaryngol Ital, 29(4), pp.197~202 (2009)
65. Nason R., "Lipopolysaccharide-induced osteoclastogenesis from mononuclear precursors : a mechanism for osteolysis in chronic otitis", J Assoc Res Otolaryngol, 10(2), pp.151~160 (2009)
66. Jung JY., "P. aeruginosa infection increases morbidity in experimental cholesteatomas", Laryngoscope, 121(11), pp.2449~2454 (2011)
67. Boyce BF., "Functions of RANKL", RANK, Arch Biochem Biophys, pp.2008, 473(2)[DOI]
68. Jeong JH., "Expression of RANKL and OPG in middle ear cholesteatoma tissue", Laryngoscope, 116(7), pp.1180~1184 (2006)
69. Sohn SJ, "Substance P upregulates osteoclastogenesis by activating nuclear factor kappa B in osteoclast precursors", Acta Otolaryngol, 125(2), pp.130~133 (2005)
70. Sherman BE., "A mechanism for sympathectomy-induced bone resorption in the middle ear", Otolaryngol Head Neck Surg, 113(5), pp.569~581 (1995)
71. Jung JY., "Nitric oxide synthase I mediates osteoclast activity in vitro and in vivo", J Cell Biochem, 89(3), pp.613~621 (2003)
72. Jung JY., "A possible role for nitric oxide in osteoclastogenesis associated with cholesteatoma", Otol Neurotol, 25(5), pp.661~668 (2004)
73. Abramson M., "Localization of collagenase in human middle ear cholesteatoma", Laryngoscope, 87(5 Pt 1), pp.771~791 (1977)
74. Moriyama H., "Bone resorption in cholesteatoma: epithelial-mesenchymal cell interaction and collagenase production", Laryngoscope, 97(7 Pt 1), pp.854~859 (1987)
75. Lazarus GS., "Plasminogen activators in epithelial biology", Semin Thromb Hemost, 17(3), pp.210~216 (1991)
76. Olszewska E., "Hexosaminidase as a new potential marker for middle ear cholesteatoma", Clin Biochem, 39(11), pp.1088~1090 (2006)
77. Olszewska E., "Role of N-acetyl-beta-d-hexosaminidase in cholesteatoma tissue", Acta Biochim Pol, 54(2), pp.365~370 (2007)
78. Olszewska E., "Cholesteatoma-associated pathogenicity : potential role of lysosomal exoglycosidases", Otol Neurotol, 33(4), pp.596~603 (2012)
79. Hansen T., "Expression of matrix-degrading cysteine proteinase cathepsin K in cholesteatoma", Mod Pathol, 14(12), pp.1226~1231 (2001)
80. Sikka K., "Evaluation of epithelial proliferation in paediatric and adult cholesteatomas using the Ki-67 proliferation marker", J Laryngol Otol, 126(5), pp.460~463 (2012)
81. Hamajima Y., "The role of inhibitor of DNA-binding(Id1)in hyperproliferation of keratinocytes : the pathological basis for middle ear cholesteatoma from chronic otitis media", Cell Prolif, 43(5), pp.457~463 (2010)
82. Mallet Y., "Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1", Laryngoscope, 113(2), pp.328~331 (2003)
83. Macias MP., "Increased amphiregulin expression as a biomarker of cholesteatoma activity", Laryngoscope, 120(11), pp.2258~2263 (2010)
84. Bujía J., "Hyperproliferation-associated keratin expression in human middle ear cholesteatoma", Acta Otolaryngol, 113(3), pp.364~368 (1993)
85. Schulz P., "Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor alpha", Am J Otolaryngol, 14(2), pp.82~87 (1993)
86. Bujia J., "Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma", Eur Arch Otorhinolaryngol, 253(1-2), pp.21~24 (1996)
87. Ergun S., "Expression of transforming growth factor-alpha and epidermal growth factor receptor in middle ear cholesteatoma", Am J Otol, 17(3), pp.393~396 (1996)
88. Kojima H., "Cell proliferation and apoptosis in human middle ear cholesteatoma", Arch Otolaryngol Head Neck Surg, 124(3), pp.261~264 (1998)
89. Shiwa M., "Expression of transforming growth factor-alpha(TGF-alpha)in cholesteatoma", J Laryngol Otol, 112(8), pp.750~754 (1998)
90. Kuczkowski J., "Expression patterns of Ki-67 and telomerase activity in middle ear cholesteatoma", Otol Neurotol, 28(2), pp.204~207 (2007)
91. Chae SW., "Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium", Laryngoscope, 110(11), pp.1898~1901 (2000)
92. Yamamoto-Fukuda T., "Expression of keratinocyte growth factor and its receptor in noncholesteatomatous and cholesteatomatous chronic otitis media", Otol Neurotol, 31(5), pp.745~751 (2010)
93. Barbara M., "Keratinocyte growth factor receptor(KGF-R)in cholesteatoma tissue", Acta Otolaryngol, 128(4), pp.360~364 (2008)
94. Lee SH., "Telomerase activity and cell proliferation index in cholesteatoma", Acta Otolaryngol, 125(7), pp.707~712 (2005)
95. Kim CS., "Interleukin-1 alpha, interleukin-1 beta and interleukin-8 gene expression in human aural cholesteatomas", Acta Otolaryngol, 116(2), pp.302~306 (1996)
96. Jung TT., "Prostaglandins in human cholesteatoma and granulation tissue", Am J Otol, 9(3), pp.197~200 (1988)
97. Sugita T., "The effect of endotoxin and prostaglandin E2 on the proliferation of keratinocytes in vitro", Arch Otorhinolaryngol, 243(3), pp.211~214 (1986)
98. Ahn JM., "Localization of interleukin-1 in human cholesteatoma", Am J Otolaryngol, 11(2), pp.71~77 (1990)
99. Yan SD., "Tumor necrosis factor alpha in middle ear cholesteatoma and its effect on keratinocytes in vitro", Ann Otol Rhinol Laryngol, 100(2), pp.157~161 (1991)
100. Kakiuchi H., "Interleukin-1 of cholesteatomatous keratinocytes", Ann Otol Rhinol Laryngol Suppl, 157, pp.32~38 (1992)
101. Schilling V., "Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear", Am J Otol, 13(4), pp.350~355 (1992)
102. Shiwa M., "Involvement of interleukin-1 in middle ear cholesteatoma", Am J Otolaryngol, 16(5), pp.319~324 (1995)
103. Sastry KV., "Aural cholesteatoma : role of tumor necrosis factor-alpha in bone destruction", Am J Otol, 20(2), pp.158~161 (1999)
104. Shibosawa E., "Stromal expression of matrix metalloprotease-9 in middle ear cholesteatomas", Am J Otol, 21(5), pp.621~624 (2000)
105. Schmidt M., "Up-regulation of matrix metalloprotease-9 in middle ear cholesteatoma : correlations with growth factor expression in vivo?", Eur Arch Otorhinolaryngol, 258(9), pp.472~476 (2001)
106. Yetiser S., "Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma", Otol Neurotol, 23(5), pp.647~652 (2002)
107. Morales DS., "Matrix metalloproteinase 2 : an important genetic marker for cholesteatomas", Braz J Otorhinolaryngol, 73(1), pp.51~57 (2007)
108. Vitale RF., "The role of tumor necrosis factor-alpha(TNF-alpha)in bone resorption present in middle ear cholesteatoma", Braz J Otorhinolaryngol, 73(1), pp.117~121 (2007)
109. Steven K. Juhn, "The Role of Inflammatory Mediators in the Pathogenesis of Otitis Media and Sequelae", Clinical and Experimental Otorhinolaryngology, 1(3), pp.117~138 (2008), 대한이비인후과학회
110. Suchozebrska-Jesionek D., "Gelatinolytic activity of matrix metalloproteinases 2 and 9 in middle ear cholesteatoma", J Otolaryngol Head Neck Surg, 37(5), pp.628~632 (2008)
111. Juhasz A., "Elevated level of tenascin and matrix metalloproteinase 9 correlates with the bone destruction capacity of cholesteatomas", Otol Neurotol, 30(4), pp.559~565 (2009)
112. Kuczkowski J., "Expression of tumor necrosis factor-α, interleukin-1α, interleukin-6 and interleukin-10 in chronic otitis media with bone osteolysis", ORL J Otorhinolaryngol Relat Spec, 73(2), pp.93~99 (2011)
113. Vitale RF., "TNF-R2 expression in acquired middle ear cholesteatoma", Braz J Otorhinolaryngol, 77(4), pp.531~536 (2011)
114. Rezende CE., "Cholesteatoma gene expression of matrix metalloproteinases and their inhibitors by RT-PCR", Braz J Otorhinolaryngol, 78(3), pp.116~121 (2012)
115. Bertolini DR., "Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors", Nature, 319(6053), pp.516~518 (1986)
116. Yan SD., "The role of tumor necrosis factor-alpha in bone resorption of cholesteatoma", Am J Otolaryngol, 12(2), pp.83~89 (1991)
117. Iino Y., "Cholesteatoma debris as an activator of human monocytes: potentiation of the production of tumor necrosis factor", Acta Otolaryngol, 110(5-6), pp.410~415 (1990)
118. Postlethwaite AE., "Interleukin 1 stimulation of collagenase production by cultured fibroblasts", J Exp Med, 157(2), pp.801~806 (1983)
119. Sun J., "Regulation of MMP-1 and MMP-2 production through CD147", extracellular matrix metalloproteinase inducer interactions, 2001, pp.61(5), 2276~2281
120. Sudhoff H., "Angiogenesis and angiogenic growth factors in middle ear cholesteatoma", Am J Otol, 21(6), pp.793~798 (2000)
121. Fujioka O., "Platelet-derived growth factor in middle ear cholesteatoma", Eur Arch Otorhinolaryngol, 251(4), pp.199~204 (1994)
122. Huang T., "Colony-stimulating factor in middle ear cholesteatoma", Am J Otolaryngol, 10(6), pp.393~398 (1989)
123. Schmidt M., "Expression of bone morphogenetic protein-2 messenger ribonucleic acid in cholesteatoma fibroblasts", Otol Neurotol, 23(3), pp.267~270 (2002)
124. Oger M., "The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence", Am J Otolaryngol, 34(6), pp.652~657 (2013)
125. Sheikholeslam-Zadeh R., "The levels of expression of galectin-3, but not of galectin-1 and galectin-8, correlate with apoptosis in human cholesteatomas", Laryngoscope, 111(6), pp.1042~1047 (2001)
126. Olszewska E., "Apoptosis in the pathogenesis of cholesteatoma in adults", Eur Arch Otorhinolaryngol, 263(5), pp.409~413 (2006)
127. Chung JH., "Expression of Apoptotic vs Antiapoptotic Proteins in Middle Ear Cholesteatoma", Otolaryngol Head Neck Surg, 153(6), pp.1024~1030 (2015)
128. Zhang W., "MicroRNA let-7a suppresses the growth and invasion of cholesteatoma keratinocytes", Mol Med Rep, 11(3), pp.2097~2103 (2015)
129. Chole RA, "Cellular and subcellular events of bone resorption in human and experimental cholesteatoma : the role of osteoclasts", Laryngoscope, 94(1), pp.76~95 (1984)
130. Hamzei M., "Osteoclast stimulating and differentiating factors in human cholesteatoma", Laryngoscope, 113(3), pp.436~442 (2003)
131. Cheshire IM., "Production of parathyroid-hormone-related protein by cholesteatoma cells in culture", Lancet, 338(8774), pp.1041~1043 (1991)
132. Berger G., "Bone resorption in chronic otitis media: the role of mast cells", Acta Otolaryngol, 100(1-2), pp.72~80 (1985)
133. Schilling V., "Immunologically activated cells in aural cholesteatoma", Am J Otolaryngol, 12(5), pp.249~253 (1991)
134. Hussein MR., "Immune cell profile in invasive cholesteatomas : preliminary findings", Exp Mol Pathol, 88(2), pp.316~323 (2010)
135. Szczepanski M., "Toll-like receptors 2, 3 and 4(TLR-2, TLR-3 and TLR-4)are expressed in the microenvironment of human acquired cholesteatoma", Eur Arch Otorhinolaryngol, 263(7), pp.603~607 (2006)
136. Schonermark M., "Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas", Acta Otolaryngol, 116(3), pp.451~456 (1996)
137. Yoon TH., "Inhibition of cholesteatomatous bone resorption with pamidronate disodium", Acta Otolaryngol, 121(2), pp.178~181 (2001)
138. Sudhoff H, "Zoledronic acid inhibits osteoclastogenesis in vitro and in a mouse model of inflammatory osteolysis", Ann Otol Rhinol Laryngol, 112(9 Pt 1), pp.780~786 (2003)
139. Klenke C., "Identification of novel cholesteatoma-related gene expression signatures using full-genome microarrays", PLoS One, 7(12), pp.e52718~ (2012)
140. Macias JD., "Differential gene expression in cholesteatoma by DNA chip analysis", Laryngoscope, 123(Suppl S5), pp.S1~S21 (2013)

관련 논문AI추천